David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
United Parcel Service
UPS
$89.9B
| $779K | ﹤0.01% |
6,975
-250,066
| -97% | -$26.5M |
|
2702
EPAM Systems
EPAM
$5.64B
| $776K | ﹤0.01% |
4,589
-1,111
| -19% | -$167K |
|
2703
Kroger
KR
$35.8B
| $772K | ﹤0.01% |
+31,400
| New | +$860K |
|
2704
PUT
Floor & Decor
FND
$5.78B
| $771K | ﹤0.01% |
18,700
| – | – |
|
2705
Sunrun
RUN
$2.2B
| $771K | ﹤0.01% |
54,852
-161,050
| -75% | -$2.22M |
|
|
ANAT
2706
DELISTED
American National Group, Inc. Common Stock
ANAT
| $771K | ﹤0.01% |
6,384
+207
| +3% | +$28.4K |
|
|
AXAS
2707
DELISTED
Abraxas Petroleum Corp
AXAS
| $771K | ﹤0.01% |
30,855
+10,940
| +55% | +$277K |
|
|
PARA
2708
CALL
DELISTED
Paramount Global Class B
PARA
| $770K | ﹤0.01% |
16,200
+7,200
| +80% | +$351K |
|
2709
PRA Group
PRAA
$732M
| $769K | ﹤0.01% |
28,667
+7,891
| +38% | +$228K |
|
2710
CALL
Steris
STE
$23.1B
| $768K | ﹤0.01% |
6,000
-6,100
| -50% | -$718K |
|
|
HZN
2711
DELISTED
Horizon Global Corporation
HZN
| $768K | ﹤0.01% |
395,689
-12,986
| -3% | -$28K |
|
|
CNSL
2712
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $767K | ﹤0.01% |
70,302
-19,266
| -22% | -$201K |
|
|
FSP
2713
Franklin Street Properties
FSP
$43.4M
| $766K | ﹤0.01% |
106,441
-94,667
| -47% | -$680K |
|
2714
Orion Group Holdings
ORN
$378M
| $765K | ﹤0.01% |
262,186
+38,095
| +17% | +$160K |
|
2715
Hawkins
HWKN
$2.48B
| $763K | ﹤0.01% |
41,450
-8,490
| -17% | -$173K |
|
2716
CALL
Canadian Pacific Kansas City
CP
$83.3B
| $762K | ﹤0.01% |
+18,500
| New | +$742K |
|
2717
PUT
Xerox
XRX
$391M
| $761K | ﹤0.01% |
23,800
| – | – |
|
2718
CALL
Wingstop
WING
$3.06B
| $760K | ﹤0.01% |
+10,000
| New | +$682K |
|
2719
PUT
Crown Holdings
CCK
$13B
| $759K | ﹤0.01% |
13,900
-31,200
| -69% | -$1.61M |
|
2720
Vipshop
VIPS
$6.7B
| $758K | ﹤0.01% |
94,403
-575,121
| -86% | -$4.07M |
|
2721
Upland Software
UPLD
$13.3M
| $757K | ﹤0.01% |
+1,788
| New | +$608K |
|
2722
Forrester Research
FORR
$223M
| $756K | ﹤0.01% |
+15,631
| New | +$728K |
|
|
VIVS
2723
VivoSim Labs
VIVS
$3.9M
| $756K | ﹤0.01% |
3,177
+1,555
| +96% | +$392K |
|
|
TRCO
2724
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $755K | ﹤0.01% |
16,374
-33,947
| -67% | -$1.56M |
|
2725
Roper Technologies
ROP
$40.9B
| $752K | ﹤0.01% |
2,200
-900
| -29% | -$273K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.